Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

October 2009

Attitude Counts at U-M Comprehensive Cancer Center

ByOnclive Team
March 8th 2010

Baby Biotechs Walk 'Valley of Death; in Search of Funding

ByOnclive Team
March 8th 2010

The Challenge of Proving Cetuximab's Value in Metastatic Colorectal Cancer

ByOnclive Team
March 8th 2010

A Global Look at H1N1

ByOnclive Team
March 8th 2010

2009 Breast Cancer Symposium

ByOnclive Team
March 8th 2010

When Breast Cancer Screening Leads to Overtreatment, Do You Stop Screening or Stop Overtreating?

ByOnclive Team
March 8th 2010

Tyrosine Kinase Inhibitors in CML

ByOnclive Team
March 8th 2010
Advertisement
Advertisement

Trending on OncLive

1

FDA Approves Iberdomide Plus Daratumumab/Dexamethasone for R/R Myeloma

2

FDA Grants Fast Track Designation to Spevatamig in Advanced and Metastatic Biliary Tract Carcinoma

3

Novel Approaches for Hematocrit Control Are Driving Research in Polycythemia Vera

4

Dr Viansone on De-Escalating Chemotherapy Type and Duration in HER2-Positive Breast Cancer

5

OncLive Weekly News Quiz (8/14/2026): Did You Catch This Week's Myeloma, Lung Cancer, and Polycythemia Vera Updates?

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us